Episode

Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2

Podcast
Oncology Today with Dr Neil Love
Published
Jul 27, 2026
Duration seconds
1773
Processing state
not_requested
Canonical source
https://oncologytoday.captivate.fm/episode/5965-cllmicro2025-rapidreview-2
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/727c7d57-6d2e-4719-a9ba-bdfe868dcf77.mp3
JSON
/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/chronic-lymphocytic-leukemia-rapid-case-review-microlearning-activity-2
Markdown
/podcast/oncology-today-with-dr-neil-love-1004241/chronic-lymphocytic-leukemia-rapid-case-review-microlearning-activity-2.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/chronic-lymphocytic-leukemia-rapid-case-review-microlearning-activity-2/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/chronic-lymphocytic-leukemia-rapid-case-review-microlearning-activity-2.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Featuring perspectives from Dr Mazyar Shadman and cases from Dr Daniel Ermann, Dr Shazia Nakhoda and Dr Mahesh Swaminathan, including the following topics: Case: A man in his mid 40s with chronic lymphocytic leukemia (CLL) receives acalabrutinib/venetoclax as part of the MAJIC trial (0:00) Case: A man in his early 70s with TP53-mutated CLL expresses concern about side effects associated with zanubrutinib (8:22) Case: A man in his late 70s with Stage IIIB chronic kidney disease and CLL receives obinutuzumab (18:02) CME information and select publications